Precision Biosciences (DTIL) Other Accumulated Expenses (2019 - 2026)

Precision Biosciences (DTIL) has 8 years of Other Accumulated Expenses data on file, last reported at $858000.0 in Q1 2026.

• Quarterly Other Accumulated Expenses fell 4.24% year-over-year to $858000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $858000.0 (down 4.24% YoY) and the FY2025 annual result came in at $649000.0, down 34.38% from the prior year.
• Other Accumulated Expenses rose to $858000.0 in Q1 2026 per DTIL's latest filing, from $649000.0 in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $2.8 million in Q1 2024 and bottomed at $611000.0 in Q3 2025.
• The 5-year median for Other Accumulated Expenses is $1.2 million (2022), against an average of $1.3 million.
• The widest annual swing landed in 2023, when Other Accumulated Expenses soared 220.94%; it then sank 67.68% in 2025.
• Tracing DTIL's Other Accumulated Expenses over 5 years: stood at $745000.0 in 2022, then soared by 220.94% to $2.4 million in 2023, then sank by 58.64% to $989000.0 in 2024, then tumbled by 34.38% to $649000.0 in 2025, then soared by 32.2% to $858000.0 in 2026.
• Per Business Quant, the three latest DTIL Other Accumulated Expenses figures stand at $858000.0 (Q1 2026), $649000.0 (Q4 2025), and $611000.0 (Q3 2025).

Peer Comparison